Showing results (871-880 of 12,112) with videos related to

Sort By:
Pageof 1,212
Neuropharmacology|April 12, 2019
The highly selective dopamine D3R antagonist, R-VK4-40 attenuates oxycodone reward and augments analgesia in rodentsChloe J Jordan, Bree Humburg, Myra Rice, et al.
Neuropharmacology|April 25, 2019
Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamineChristopher L Shaffer, Jason K Dutra, Wei Chou Tseng, et al.
Neuropharmacology|April 30, 2019
Probiotic treatment restores normal developmental trajectories of fear memory retention in maternally separated infant ratsHsuan-Hui Peng, Tsung-Chih Tsai, Wan-Yu Huang, et al.
Neuropharmacology|April 10, 2019
Evidence for nonlinear accumulation of the ultrapotent fentanyl analog, carfentanil, after systemic administration to male ratsMarianne Skov-Skov Bergh, Inger Lise Bogen, Nancy Garibay, et al.
Neuropharmacology|October 17, 2018
Mechanisms underlying prelimbic prefrontal cortex mGlu3/mGlu5-dependent plasticity and reversal learning deficits following acute stressMax E Joffe, Chiaki I Santiago, Branden J Stansley, et al.
Neuropharmacology|May 1, 1986
Proconflict effect of GABA receptor complex antagonists. Reversal by diazepamM G Corda, G Biggio
Neuropharmacology|September 3, 2018
Suramin is a novel competitive antagonist selective to α1β2γ2 GABAA over ρ1 GABAC receptorsHui Luo, Kristofer Wood, Fu-Dong Shi, et al.
Neuropharmacology|August 27, 2018
Developmental role of adenosine kinase for the expression of sex-dependent neuropsychiatric behaviorD M Osborne, U S Sandau, A T Jones, et al.
Neuropharmacology|January 1, 1987
Behavioural and electrocortical spectrum power effects of growth hormone releasing factor in ratsG Nisticò, G B De Sarro, G Bagetta, et al.
Neuropharmacology|September 22, 2018
Hippocampal NPY Y2 receptors modulate memory depending on emotional valence and timeBirgit A Hörmer, Dilip Verma, Elisabeth Gasser, et al.
Pageof 1,212